loadpatents
Patent applications and USPTO patent grants for Akbari; Parsa.The latest application filed is for "methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta e (inhbe) inhibitors".
Patent | Date |
---|---|
Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors App 20220184114 - Lotta; Luca Andrea ;   et al. | 2022-06-16 |
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors Grant 11,359,246 - Lotta , et al. June 14, 2 | 2022-06-14 |
Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR) App 20220049308 - Lotta; Luca Andrea ;   et al. | 2022-02-17 |
Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors App 20220042101 - Lotta; Luca Andrea ;   et al. | 2022-02-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.